Article info

Download PDFPDF

Original research
Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors

Authors

  1. Correspondence to Dr Burak Sahin; burak.sahin{at}pfizer.com
View Full Text

Citation

Weitz JI, Szekanecz Z, Charles-Schoeman C, et al
Biomarkers to predict risk of venous thromboembolism in patients with rheumatoid arthritis receiving tofacitinib or tumour necrosis factor inhibitors

Publication history

  • Received July 25, 2022
  • Accepted September 15, 2022
  • First published November 2, 2022.
Online issue publication 
June 27, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.